Literature DB >> 11593430

HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.

D G Bosc1, B S Goueli, R Janknecht.   

Abstract

In this study, we show that the ETS transcription factor ER81 directly binds to and activates the promoter of the matrix metalloproteinase gene, MMP-1. Further, the oncoprotein HER2/Neu synergizes with ER81 to stimulate MMP-1 transcription. The activation of ER81 by HER2/Neu is mediated by MAP kinases, which phosphorylate ER81 in its N-terminal activation domain. Four respective phosphorylation sites have been identified. Blocking phosphorylation at these sites decreases ER81 transcriptional activity, which can be further diminished by abolishment of phosphorylation at two non-MAP kinase sites. Altogether, our results reveal mechanisms of how phosphorylation of ER81 regulates the expression of target genes such as MMP-1, which may be important for many physiological processes from embryogenesis to adulthood as well as for tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593430     DOI: 10.1038/sj.onc.1204820

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

2.  Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors.

Authors:  Jing Zhou; Constance Brinckerhoff; Susan Lubert; Kui Yang; Jasmine Saini; Jeffrey Hooke; Richard Mural; Craig Shriver; Stella Somiari
Journal:  Cancer Invest       Date:  2011-11       Impact factor: 2.176

3.  The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.

Authors:  Baoqiang Guo; Rosemary E Sallis; Amanda Greenall; Marleen M R Petit; Erik Jansen; Leonie Young; Wim J M Van de Ven; Andrew D Sharrocks
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.

Authors:  Sungeun Kim; Christopher T Denny; Ron Wisdom
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 5.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

Review 6.  ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta       Date:  2012-03-08

7.  Differential regulation of dopaminergic gene expression by Er81.

Authors:  John W Cave; Yosuke Akiba; Kasturi Banerjee; Shivraj Bhosle; Roseann Berlin; Harriet Baker
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

8.  ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Authors:  Sook Shin; Sangphil Oh; Seayoon An; Ralf Janknecht
Journal:  Oncol Rep       Date:  2012-10-16       Impact factor: 3.906

9.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.

Authors:  Tae-Dong Kim; Fang Jin; Sook Shin; Sangphil Oh; Stan A Lightfoot; Joseph P Grande; Aaron J Johnson; Jan M van Deursen; Jonathan D Wren; Ralf Janknecht
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.